4//SEC Filing
Reider Paul 4
Accession 0001610717-23-000165
CIK 0001512762other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:39 PM ET
Size
5.3 KB
Accession
0001610717-23-000165
Insider Transaction Report
Form 4
Reider Paul
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+70,000→ 70,000 totalExercise: $5.44Exp: 2033-06-13→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001970033
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:39 PM ET
- Size
- 5.3 KB